DEBAR Act of 2021

Debarment Enforcement of Bad Actor Registrants Act of 2021 or the DEBAR Act of 2021

This bill authorizes the Drug Enforcement Administration (DEA) to bar an entity from registering to manufacture, distribute, or dispense controlled substances under certain circumstances.

Specifically, the DEA may bar—temporarily or permanently—the registration of an entity that (1) meets or has met any condition for suspension or revocation of the registration, and (2) has a history of prior suspensions or revocations.

[117th Congress Public Law 36]
[From the U.S. Government Publishing Office]



[[Page 135 STAT. 328]]

Public Law 117-36
117th Congress

                                 An Act


 
  To amend the Controlled Substances Act to authorize the debarment of 
      certain registrants, and for other purposes. <<NOTE: Aug. 6, 
                         2021 -  [H.R. 1002]>> 

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled, <<NOTE: Debarment 
Enforcement of Bad Actor Registrants Act of 2021. 21 USC 801 note.>> 
SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Debarment Enforcement of Bad Actor 
Registrants Act of 2021'' or the ``DEBAR Act of 2021''.
SEC. 2. DEBARMENT OF CERTAIN REGISTRANTS.

    Section 304 of the Controlled Substances Act (21 U.S.C. 824) is 
amended by adding at the end the following:
    ``(h) The Attorney General may issue an order to prohibit, 
conditionally or unconditionally, and permanently or for such period as 
the Attorney General may determine, any person from being registered 
under this title to manufacture, distribute, or dispense a controlled 
substance or a list I chemical, if the Attorney General finds that--
            ``(1) such person meets or has met any of the conditions for 
        suspension or revocation of registration under subsection (a); 
        and
            ``(2) such person has a history of prior suspensions or 
        revocations of registration.''.
SEC. 3. DETERMINATION OF BUDGETARY EFFECTS.

    The budgetary effects of this Act, for the purpose of complying with 
the Statutory Pay-As-You-Go Act of 2010, shall be determined by 
reference to the latest statement titled ``Budgetary Effects of PAYGO 
Legislation'' for this Act, submitted for printing in the Congressional 
Record by the Chairman of the House Budget Committee, provided that such 
statement has been submitted prior to the vote on passage.

    Approved August 6, 2021.

LEGISLATIVE HISTORY--H.R. 1002:
---------------------------------------------------------------------------

CONGRESSIONAL RECORD, Vol. 167 (2021):
            Apr. 14, 15, considered and passed House.
            July 27, considered and passed Senate.

                                  <all>